会计年度:2021-12-31收入分布
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
工业 | 7,333,842,674.30 | 1,106,858,238.37 | 6,226,984,435.93 | 84.91 |
合计 | 7,630,510,000.18 | 1,276,564,038.73 | 6,353,945,961.45 | 83.27 |
其他(补充) | 13,004,996.16 | 8,786,155.94 | 4,218,840.22 | 32.44 |
其中:儿科类 | 1,700,641,987.73 | 189,101,156.93 | 1,511,540,830.80 | 88.88 |
其中:妇科类 | 58,986,873.05 | 18,206,239.67 | 40,780,633.38 | 69.14 |
其中:呼吸类 | 481,137,171.06 | 62,470,156.39 | 418,667,014.67 | 87.02 |
其中:其他 | 783,476,755.10 | 163,348,088.74 | 620,128,666.36 | 79.15 |
其中:清热解毒类 | 2,422,065,664.97 | 477,060,229.24 | 1,945,005,435.73 | 80.30 |
其中:消化类 | 1,804,454,858.57 | 149,090,467.22 | 1,655,364,391.35 | 91.74 |
其中:心脑血管类 | 83,079,363.82 | 47,581,900.18 | 35,497,463.64 | 42.73 |
商业 | 283,662,329.72 | 160,919,644.42 | 122,742,685.30 | 43.27 |
|
会计年度:2020-12-31
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
工业 | 5,930,169,046.67 | 972,396,244.69 | 4,957,772,801.98 | 83.60 |
合计 | 6,164,974,167.54 | 1,130,253,931.44 | 5,034,720,236.10 | 81.67 |
其他(补充) | 14,254,820.88 | 7,363,053.01 | 6,891,767.87 | 48.35 |
其中:儿科类 | 1,037,922,172.02 | 132,873,315.64 | 905,048,856.38 | 87.20 |
其中:妇科类 | 62,206,829.02 | 16,508,284.84 | 45,698,544.18 | 73.46 |
其中:呼吸类 | 279,712,878.17 | 41,414,027.77 | 238,298,850.40 | 85.19 |
其中:其他 | 642,703,066.77 | 137,588,646.26 | 505,114,420.51 | 78.59 |
其中:清热解毒类 | 2,140,372,764.21 | 459,410,323.53 | 1,680,962,440.68 | 78.54 |
其中:消化类 | 1,689,698,155.54 | 144,877,207.46 | 1,544,820,948.08 | 91.43 |
其中:心脑血管类 | 77,553,180.94 | 39,724,439.19 | 37,828,741.75 | 48.78 |
商业 | 220,550,299.99 | 150,494,633.74 | 70,055,666.25 | 31.76 |
|
会计年度:2019-12-31
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
儿科类 | 1,524,909,591.71 | 167,087,000.78 | 1,357,822,590.93 | 89.04 |
妇科类 | 73,173,627.72 | 14,692,378.83 | 58,481,248.89 | 79.92 |
工业 | 6,680,600,340.30 | 912,440,620.40 | 5,768,159,719.90 | 86.34 |
合计 | 6,939,993,811.61 | 1,110,230,721.51 | 5,829,763,090.10 | 84.00 |
呼吸类 | 430,159,850.26 | 45,992,194.93 | 384,167,655.33 | 89.31 |
其他 | 612,248,272.27 | 115,119,108.28 | 497,129,163.99 | 81.20 |
其他(补充) | 18,322,436.49 | 7,413,181.19 | 10,909,255.30 | 59.54 |
清热解毒类 | 2,347,847,728.04 | 423,720,972.83 | 1,924,126,755.21 | 81.95 |
商业 | 241,071,034.82 | 190,376,919.92 | 50,694,114.90 | 21.03 |
消化类 | 1,608,463,329.39 | 115,694,618.29 | 1,492,768,711.10 | 92.81 |
心脑血管类 | 83,797,940.91 | 30,134,346.46 | 53,663,594.45 | 64.04 |
|
会计年度:2018-12-31
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
儿科类 | 1,245,655,375.70 | 134,351,552.34 | 1,111,303,823.36 | 89.21 |
妇科类 | 74,157,068.63 | 17,272,462.34 | 56,884,606.29 | 76.71 |
工业 | 6,972,968,645.71 | 903,529,616.64 | 6,069,439,029.07 | 87.04 |
合计 | 7,208,205,788.59 | 1,096,106,273.43 | 6,112,099,515.16 | 84.79 |
呼吸类 | 336,131,427.25 | 36,697,081.30 | 299,434,345.95 | 89.08 |
其他 | 594,420,177.17 | 99,035,060.09 | 495,385,117.08 | 83.34 |
其他(补充) | 11,148,508.32 | 4,041,620.56 | 7,106,887.76 | 63.75 |
清热解毒类 | 3,195,167,049.10 | 494,272,206.89 | 2,700,894,842.21 | 84.53 |
商业 | 224,088,634.56 | 188,535,036.23 | 35,553,598.33 | 15.87 |
消化类 | 1,447,573,990.14 | 99,167,313.90 | 1,348,406,676.24 | 93.15 |
心脑血管类 | 79,863,557.72 | 22,733,939.77 | 57,129,617.95 | 71.53 |
|
会计年度:2017-12-31
|
项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
儿科类 | 904,220,834.18 | 95,671,765.59 | 808,549,068.59 | 89.42 |
妇科类 | 66,421,631.91 | 14,511,142.89 | 51,910,489.02 | 78.15 |
工业 | 5,427,225,163.56 | 676,140,989.70 | 4,751,084,173.86 | 87.54 |
合计 | 5,633,003,137.21 | 845,330,268.87 | 4,787,672,868.34 | 84.99 |
呼吸类 | 243,234,542.18 | 30,208,489.12 | 213,026,053.06 | 87.58 |
其他 | 399,527,988.91 | 70,186,404.09 | 329,341,584.82 | 82.43 |
清热解毒类 | 2,481,203,843.24 | 362,210,266.92 | 2,118,993,576.32 | 85.40 |
商业 | 205,777,973.65 | 169,189,279.17 | 36,588,694.48 | 17.78 |
消化类 | 1,252,285,430.86 | 80,149,985.00 | 1,172,135,445.86 | 93.60 |
心脑血管类 | 80,330,892.30 | 23,202,936.09 | 57,127,956.21 | 71.12 |
|